Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Accounts Payables (2022 - 2026)

HeartSciences' Accounts Payables history spans 5 years, with the latest figure at $410727.0 for Q1 2026.

  • For Q1 2026, Accounts Payables rose 1.4% year-over-year to $410727.0; the TTM value through Jan 2026 reached $410727.0, up 1.4%, while the annual FY2025 figure was $318661.0, 28.9% down from the prior year.
  • Accounts Payables reached $410727.0 in Q1 2026 per HSCS's latest filing, up from $317390.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.1 million in Q4 2023 to a low of $276848.0 in Q4 2024.
  • Average Accounts Payables over 5 years is $527040.0, with a median of $431629.5 recorded in 2024.
  • Peak YoY movement for Accounts Payables: soared 36.85% in 2023, then crashed 74.56% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $795266.0 in 2022, then skyrocketed by 36.85% to $1.1 million in 2023, then plummeted by 74.56% to $276848.0 in 2024, then increased by 14.64% to $317390.0 in 2025, then rose by 29.41% to $410727.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Accounts Payables are $410727.0 (Q1 2026), $317390.0 (Q4 2025), and $283225.0 (Q3 2025).